cancer

Over the next three weeks, Congress has an opportunity to reverse decades of declining support for a program that is vital to our nation’s public health. House and Senate appropriators will soon determine how to allocate $25 billion in additional non-defense discretionary spending for fiscal year (FY) 2016 before the continuing resolution expires on December 11. They now have the opportunity to address the damage resulting from years’ long stagnation in federally-funded research and reinvest in the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Supporters of Research!America are fully aware of the decline in our federal research enterprise. The lack of...
As many as one-half of all cancers are preventable based on what we already understand. Despite many promising and innovative new therapies, cancer prevention remains “Plan A,” our first and best hope to reduce the burden of this disease. I recently shared key points of this plan, described below, in a June 1, 2015 lecture at the American Society of Clinical Oncology Annual Meeting. At The University of Texas MD Anderson Cancer Center , we established the cancer prevention and control platform within the Moon Shots program. Our mission is to develop and implement evidence-based actions in cancer prevention, screening, early detection and survivorship in clinical and community settings to...
November 20, 2014 Congressman Tom Cole’s leadership on the Labor-HHS-Education subcommittee will help shape our ability to sustain and accelerate medical innovation as we confront health crises here and abroad. As a steward of the federal funding that lays the noncommercial foundation for private sector medical progress, Congressman Cole will play a pivotal role in determining whether our nation conquers Alzheimer’s, childhood cancer, Ebola and other insidious health threats. We commend his efforts to ensure quality health care for veterans, remove barriers to innovation through the repeal of the medical device tax and advance other health and research-related initiatives. We look forward...
Excerpt of a joint op-ed by Research!America President and CEO Mary Woolley and Susan G. Komen President and CEO Judith A. Salerno published in The Huffington Post . February 23, 1954, was a milestone in the history of American medical research. That day, children at Arsenal Elementary School in Pittsburgh lined up to receive injections of a promising vaccine. Within months, schoolchildren all over the country were doing the same, and polio was on its way to being eradicated in the United States. The disease, which had killed and paralyzed children and adults alike, would no longer be a threat. This remarkable achievement would not have been possible without the work of Dr. Jonas Salk and...
Research!America applauds Senator Tom Harkin for taking bold, decisive action to heal fissures in our nation’€™s research pipeline with legislation that will strengthen the National Institutes of Health (NIH) budget over the next six years. The Accelerate Biomedical Research Act will establish a pathway for sustained growth in the NIH budget. That budget has remained virtually stagnant over the last decade, jeopardizing promising research to combat disease and deflating the aspirations of early career scientists. NIH-funded research fuels the development of lifesaving therapies and treatments, and creates opportunities for public-private partnerships to better understand Alzheimer’€™s,...
Research!America’€™s newest fact sheet series highlights the personal stories of medical research and the importance of increasing the NIH budget in FY15. We hope you will share these fact sheets with your representatives or congressional candidates, or take it with you on Hill or in-district visits. No one who reads these stories can doubt the significance of medical progress. A stronger investment in research is needed now more than ever! Here are their stories: John Hudson Dilgen, Epidermolysis Bullosa Steve DeWitte, Parkinson’s disease Victor Medina, Traumatic Brain Injury Carrie Scott, Multiple Sclerosis Max Hasenauer, X-linked agammaglobulinemia Michael Moskowitz, non-Hodgkin’s...
Leading up to Father’€™s Day and as part of National Men’€™s Health Week, the American Cancer Society is raising awareness about risk factors for cancer in men. Among the cancer threats men face, prostate cancer is particularly lethal. In fact, it is the 2nd most deadly cancer for American men behind lung cancer. This year alone in the United States, an estimated 233,000 men will be diagnosed with prostate cancer and 29,480 men will die from the disease. Prostate cancer is also one of the most costly forms of cancer, with $11.9 billion spent on treatment each year in the US. Despite these grim statistics, significant progress has been made in the area of prostate cancer research...
By Margaret Foti, PhD, MD (h.c.), Chief Executive Officer, American Association for Cancer Research Each year, the American Association for Cancer Research (AACR) is pleased to support and highlight May as National Cancer Research Month. Throughout this special month, the AACR celebrates the accomplishments of the scientific community, advocates for funding increases for the National Institutes of Health (NIH) and the National Cancer Institute (NCI), and spotlights the need for continued improvements in patient care. There’€™s no doubt that tremendous progress has been made against cancer. People who have been diagnosed with cancer are living longer today than ever before. The five-year...
Excerpt of an article by Research!America VP of Communications Suzanne Ffolkes and Communications Specialist Anna Briseno, published in Elsevier Connect . A panel hosted by Research!America and the Pancreatic Cancer Action Network discusses challenges and opportunities for advancing cancer research Julie Fleshman’s journey to improve outcomes for pancreatic cancer patients was inspired by her father, who died four months after receiving the diagnosis. That was in 1999. Since then, she’s been advocating for research to support early diagnosis and better treatments. “That passion drives me every day ’€“ anger mixed with hope and optimism of the future,” she said. Fleshman , President and CEO...
Dear Research Advocate: People everywhere are captivated by the world-class athletes competing at the Winter Olympics. The personal commitment, dedication and motivation on display is certainly an essential ingredient for medalling, but it is not sufficient: Each nation fielding a team must commit to supporting sustained excellence. And both the public and private sectors play a role. There are some interesting parallels to science and innovation ’€” we don’€™t see it in the public eye every day but when it comes to the fore, it’€™s the kind of success that affirms the human spirit in a compelling way. When lives are saved with a new therapy or new vaccine, we all take heart and we...

Pages

Sidebar Quote

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana